Robeco Institutional Asset Management B.V. boosted its position in shares of Exelon Co. (NASDAQ:EXC – Free Report) by 101.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,344,978 shares of the company’s stock after acquiring an additional 678,490 shares during the period. Robeco Institutional Asset Management B.V. owned 0.13% of Exelon worth $54,539,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. raised its position in shares of Exelon by 16.3% in the first quarter. Vanguard Group Inc. now owns 105,310,761 shares of the company’s stock worth $3,956,525,000 after buying an additional 14,749,899 shares in the last quarter. Clearbridge Investments LLC grew its holdings in shares of Exelon by 10.5% during the first quarter. Clearbridge Investments LLC now owns 1,645,737 shares of the company’s stock worth $61,830,000 after purchasing an additional 156,201 shares in the last quarter. Czech National Bank raised its stake in Exelon by 8.8% in the second quarter. Czech National Bank now owns 190,537 shares of the company’s stock valued at $6,594,000 after purchasing an additional 15,389 shares in the last quarter. Sciencast Management LP bought a new stake in Exelon during the first quarter valued at approximately $1,461,000. Finally, Acadian Asset Management LLC purchased a new position in Exelon in the 1st quarter worth approximately $681,000. Institutional investors own 80.92% of the company’s stock.
Exelon Stock Down 0.5 %
Shares of NASDAQ:EXC opened at $37.97 on Tuesday. The stock’s 50-day moving average is $39.66 and its 200 day moving average is $37.74. The company has a market cap of $38.15 billion, a PE ratio of 15.63, a P/E/G ratio of 2.84 and a beta of 0.54. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.09 and a quick ratio of 0.93. Exelon Co. has a 1 year low of $33.35 and a 1 year high of $41.42.
Exelon Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Monday, November 11th will be paid a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a yield of 4.00%. The ex-dividend date is Friday, November 8th. Exelon’s payout ratio is currently 62.55%.
Analysts Set New Price Targets
A number of analysts have recently issued reports on the stock. Scotiabank lifted their price objective on shares of Exelon from $37.00 to $40.00 and gave the stock a “sector perform” rating in a report on Tuesday, August 20th. Jefferies Financial Group assumed coverage on Exelon in a report on Thursday, September 19th. They issued a “buy” rating and a $46.00 price objective for the company. Morgan Stanley raised their price objective on Exelon from $42.00 to $45.00 and gave the company an “equal weight” rating in a report on Wednesday, September 25th. Wells Fargo & Company increased their price target on shares of Exelon from $40.00 to $42.00 and gave the company an “equal weight” rating in a research report on Friday, August 2nd. Finally, UBS Group boosted their price objective on shares of Exelon from $40.00 to $43.00 and gave the stock a “neutral” rating in a report on Friday, September 20th. Eleven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, Exelon has a consensus rating of “Hold” and a consensus price target of $41.33.
Get Our Latest Stock Analysis on Exelon
Exelon Company Profile
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Read More
- Five stocks we like better than Exelon
- What is Put Option Volume?
- Intel: Is Now the Time to Be Brave?Â
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.